Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026282
Filing Date
2021-11-12
Accepted
2021-11-12 07:30:58
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20210930_10q.htm   iXBRL 10-Q 1070924
2 EXHIBIT 31.1 ex_298571.htm EX-31.1 12492
3 EXHIBIT 31.2 ex_298572.htm EX-31.2 12336
4 EXHIBIT 32.1 ex_298573.htm EX-32.1 6948
10 plx01.jpg GRAPHIC 5305
  Complete submission text file 0001437749-21-026282.txt   4801992

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA plxp-20210930.xsd EX-101.SCH 38185
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20210930_cal.xml EX-101.CAL 39060
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20210930_def.xml EX-101.DEF 310550
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20210930_lab.xml EX-101.LAB 300082
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20210930_pre.xml EX-101.PRE 329209
11 EXTRACTED XBRL INSTANCE DOCUMENT plxp20210930_10q_htm.xml XML 598486
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 211399584
SIC: 2834 Pharmaceutical Preparations